Today: 3 July 2026
Browse Category

NASDAQ:SXTC 9 January 2026

Stock Market Today

  • Scribe Therapeutics files for Nasdaq IPO, tests early-stage biotech demand
    July 2, 2026, 8:46 PM EDT. Scribe Therapeutics filed for a Nasdaq IPO under the ticker SCTX. The biotech is working on gene editing, but its lead programs haven't hit Phase 3 yet. Investors have shown interest in earlier-stage biotechs, though many are still watching for late-stage results before going bigger.
Go toTop